MicroRNA-132 may play a role in coexistence of depression and cardiovascular disease: A hypothesis

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 438-443

  Zheng, Zhihua ^a   Zeng, Yingtong ^b   Huang, Hongbing ^c   Xu, Feng ^d  

^a Guangdong Province Pharmaceutical Association   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cardiovascular disease; Depression; microRNA 132; Neuroplasticity

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTEROID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID; MICRORNA 132; VASCULOTROPIN;

ARTICLE; CARDIOVASCULAR DISEASE; CHROMOSOME 17; COGNITION; DEPRESSION; DISEASE ASSOCIATION; ENDOTHELIUM; GLIA CELL; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; META ANALYSIS (TOPIC); NERVE CELL DEGENERATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NORADRENERGIC NERVE; PREFRONTAL CORTEX; RISK FACTOR; RNA TRANSLATION; SEQUENCE HOMOLOGY;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DEPRESSION; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; NEURONAL PLASTICITY;

EID: 84878972502     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883935     Document Type: Article

References (73)

1. Cramer SC, Sur M, Dobkin BH et al: Harnessing neuroplasticity for clinical applications. Brain, 2011; 134: 1591-609
2. Zheng Z, Xu F: Neuroplasticity may play a role in inter-individual difference among neuropsychiatric disease treatment efficacy. Dev Psychobiol, 2012; 54: 369-71
3. Bulik CM, Wade TD, Kendler KS: Characteristics of monozygotic twins discordant for bulimia nervosa. Int J Eat Disord, 2001; 29: 1-10
4. Cannon TD, Huttunen MO, Lonnqvist J et al: The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia. Am J Hum Genet, 2000; 67: 369-82
5. Gourovitch ML, Torrey EF, Gold JM et al: Neuropsychological performance of monozygotic twins discordant for bipolar disorder. Biol Psychiatry, 1999; 45: 639-46
6. Hall LS, Love CT: Finger-length ratios in female monozygotic twins discordant for sexual orientation. Arch Sex Behav, 2003; 32: 23-28
7. Kolb B, Teskey GC: Age, experience, injury, and the changing brain. Dev Psychobiol, 2012; 54: 369-71
8. Ariyo AA, Haan M, Tangen CM et al: Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation, 2000; 102: 1773-79
9. Abramson J, Berger A, Krumholz HM, Vaccarino V: Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med, 2001; 161: 1725-30
10. Williams SA, Kasl SV, Heiat A et al: Depression and risk of heart failure among the elderly: a prospective community - based study. Psychosom Med, 2002; 64: 6-12
11. Gump BB, Matthews KA, Eberly LE, Chang YF: Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial. Stroke, 2005; 36: 98-102
12. Ahto M, Isoaho R, Puolijoki H, Vahlberg T, Kivela SL: Stronger symptoms of depression predict high coronary heart disease mortality in older men and women. Int J Geriatr Psychiatry, 2007; 22: 757-63
13. Surtees PG, Wainwright NW, Luben RN et al: Depression and ischemic heart disease mortality: evidence from the EPIC-Norfolk United Kingdom prospective cohort study. Am J Psychiatry, 2008; 165: 515-23
14. Kendler KS, Gardner CO, Fiske A, Gatz M: Major depression and coronary artery disease in the Swedish twin registry: phenotypic, genetic, and environmental sources of comorbidity. Arch Gen Psychiatry, 2009; 66: 857-63
15. Baune BT, Stuart M, Gilmour A et al: The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models. Transl Psychiatry, 2012; 2: e92
16. Meijer A, Conradi HJ, Bos EH et al: Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry, 2011; 33: 203-16
17. van Melle JP, de Jonge P, Spijkerman TA et al: Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med, 2004; 66: 814-22
18. Masi G, Brovedani P: The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. CNS Drugs, 2011; 25: 913-31
19. Llorens-Martin M, Trejo JL: Mifepristone Prevents Stress-Induced Apoptosis in Newborn Neurons and Increases AMPA Receptor Expression in the Dentate Gyrus of C57/BL6 Mice. PLoS One, 2011; 6: e28376.
20. O'Sullivan E, Barrett E, Grenham S et al: BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels? Benef Microbes, 2011; 2: 199-207
21. Pittenger C, Duman RS: Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology, 2008; 33: 88-109
22. Rush AJ, Fava M, Wisniewski SR et al: Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials, 2004; 25: 119-42
23. Berninger B, Schinder AF, Poo MM: Synaptic reliability correlates with reduced susceptibility to synaptic potentiation by brain-derived neurotrophic factor. Learn Mem, 1999; 6: 232-42
24. Thoenen H: Neurotrophins and neuronal plasticity. Science, 1995; 270: 593-98
25. Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorders. Biol Psychiatry, 2006; 59: 1116-27
26. Duman RS, Heninger GR, Nestler EJ: A molecular and cellular theory of depression. Arch Gen Psychiatry, 1997; 54: 597-606
27. Numakawa T, Yokomaku D, Richards M et al: Functional interactions between steroid hormones and neurotrophin BDNF. World J Biol Chem, 2010; 1: 133-43
28. Kutiyanawalla A, Terry AV Jr, Pillai A: Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment. PLoS One, 2011; 6: e26153
29. Lee TH, Kato H, Chen ST et al: Expression disparity of brain-derived neurotrophic factor immunoreactivity and mRNA in ischemic hippocampal neurons. Neuroreport, 2002; 13: 2271-75
30. Gould E: Serotonin and hippocampal neurogenesis. Neuropsychopharmacology, 1999; 21: 46S-51S
31. Forsgren S, Grimsholm O, Dalen T et al: Measurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment. Int J Inflam, 2011; 2011: 650685
32. Yoshimura R, Kishi T, Suzuki A et al: The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients. Prog Neuropsychopharmacol Biol Psychiatry, 2011; 35: 1022-25
33. Ebert MS, Neilson JR, Sharp PA: MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nature Methods, 2007; 4: 721-26
34. Herranz H, Cohen SM: MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems. Genes Dev, 2010; 24: 1339-44
35. Kosik KS: The neuronal microRNA system. Nat Rev Neurosci, 2006; 7: 911-20
36. Lim LP, Lau NC, Garrett-Engele P et al: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 2005; 433: 769-73
37. Lewis BP, Shih IH, Jones-Rhoades MW et al: Prediction of mammalian microRNA targets. Cell, 2003; 115: 787-98
38. Scott HL, Tamagnini F, Narduzzo KE et al: MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci, 2012; 36: 2941-48
39. Nudelman AS, DiRocco DP, Lambert TJ et al: Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus, 2010; 20: 492-98
40. Vo N, Klein ME, Varlamova O et al: A cAMP-response element binding protein- induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci USA, 2005; 102: 16426-31
41. Impey S, McCorkle SR, Cha-Molstad H et al: Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell, 2004; 119: 1041-54
42. Wayman GA, Davare M, Ando H et al: An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci USA, 2008; 105: 9093-98
43. Cheng HY, Papp JW, Varlamova O et al: microRNA modulation of circadianclock period and entrainment. Neuron, 2007; 54: 813-29
44. Luikart BW, Bensen AL, Washburn EK et al: miR-132 mediates the integration of newborn neurons into the adult dentate gyrus. PLoS One, 2011; 6: e19077
45. Edbauer D, Neilson JR, Foster KA et al: Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron, 2010; 65: 373-84
46. Hansen KF, Sakamoto K, Wayman GA et al: Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory. PLoS One, 2010; 5: e15497
47. Impey S, Davare M, Lesiak A et al: An activity-induced microRNA controls dendritic spine formation by regulating Rac1-PAK signaling. Mol Cell Neurosci, 2010; 43: 146-56
48. Magill ST, Cambronne XA, Luikart BW et al: microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci USA, 2010; 107: 20382-87
49. Lambert TJ, Storm DR, Sullivan JM: MicroRNA132 modulates short-term synaptic plasticity but not basal release probability in hippocampal neurons. PLoS One, 2010; 5: e15182
50. Numakawa T, Richards M, Adachi N et al: MicroRNA function and neurotrophin BDNF. Neurochem Int, 2011; 59: 551-58
51. Numakawa T, Suzuki S, Kumamaru E et al: BDNF function and intracellular signaling in neurons. Histol Histopathol, 2010; 25: 237-58
52. Kawashima H, Numakawa T, Kumamaru E et al: Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression. Neuroscience, 2010; 165: 1301-11
53. Mattson MP, Wan R: Neurotrophic factors in autonomic nervous system plasticity and dysfunction. Neuromolecular Med, 2008; 10: 157-68
54. Martin JL, Jenkins VK, Hsieh HY, Balkowiec A: Brain-derived neurotrophic factor in arterial baroreceptor pathways: implications for activity-dependent plasticity at baroafferent synapses. J Neurochem, 2009; 108: 450-64
55. Noble EE, Billington CJ, Kotz CM, Wang C: The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol, 2011; 300: R1053-69
56. Taliaz D, Loya A, Gersner R et al: Resilience to chronic stress is mediated by hippocampal brain-derived neurotrophic factor. J Neurosci, 2011; 31: 4475-83
57. Jeanneteau FD, Lambert WM, Ismaili N et al: BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proc Natl Acad Sci USA, 2012; 109: 1305-10
58. Chaldakov G: The metabotrophic NGF and BDNF: an emerging concept. Arch Ital Biol, 2011; 149: 257-63
59. Speer T, Rohrer L, Blyszczuk P et al: Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-Like Receptor-2. Immunity, 2013; 38(4): 754-68
60. Liu W, Peng Y, Wu B et al: A Meta-Analysis of the Impact of EPC Capture Stent on the Clinical Outcomes in Patients with Coronary Artery Disease. J Interv Cardiol, 2013, [Epub ahead of print]
61. Lerman A, Zeiher AM: Endothelial function: cardiac events. Circulation, 2005; 111: 363-68
62. Waltenberger J: VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus. Biochem Soc Trans, 2009; 37: 1167-70
63. Holmes DI, Zachary I: The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol, 2005; 6: 209
64. Xu S, Jin C, Shen X et al: MicroRNAs as potential novel therapeutic targets and tools for regulating paracrine function of endothelial progenitor cells. Med Sci Monit, 2012; 18(7): HY27-31
65. Anand S, Cheresh DA: MicroRNA-mediated regulation of the angiogenic switch. Curr Opi Hematol, 2011; 18: 171-76
66. Jin W, Reddy MA, Chen Z et al: Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. J Biol Chem, 2012; 287: 15672-83
67. Hanson M, Gluckman P: Endothelial dysfunction and cardiovascular disease: the role of predictive adaptive responses. Heart, 2005; 91: 864-66
68. Donovan MJ, Lin MI, Wiegn P et al: Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development, 2000; 127: 4531-40
69. Katare R, Riu F, Mitchell K et al: Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res, 2011; 109: 894-906
70. 2+ channels by MicroRNAs during longterm exposure to isoproterenol in rats. J Cardiovasc Pharmacol, 2011; 58: 470-78
71. Deregibus MC, Tetta C, Camussi G: The dynamic stem cell microenvironment is orchestrated by microvesicle-mediated transfer of genetic information. Histol Histopathol, 2010; 25: 397-404
72. Ceman S, Saugstad J: MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease. Pharmacol Ther, 2011; 130: 26-37
73. Smalheiser NR: Do Neural Cells Communicate with Endothelial Cells via Secretory Exosomes and Microvesicles? Cardiovasc Psychiatry Neurol, 2009; 2009: 383086